Rationale: Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder in which inflammation and immunity have emerged as critical early pathogenic elements. Although proinflammatory processes in PH and pulmonary arterial hypertension (PAH) are the focus of extensive investigation, the initiating mechanisms remain elusive. Objectives: We tested whether activation of the complement cascade is critical in regulating proinflammatory and proproliferative processes in the initiation of experimental hypoxic PH and can serve as a prognostic biomarker of outcome in human PAH. Methods: We used immunostaining of lung tissues from experimental PH models and patients with PAH, analyses of genetic murine models lacking specific complement components or circulating immunoglobulins, cultured human pulmonary adventitial fibroblasts, and network medicine analysis of a biomarker risk panel from plasma of patients with PAH.
experimental animal models and humans. In experimental hypoxic PH, proinflammatory and pro-proliferative responses were dependent on complement (alternative pathway and component 5), and immunoglobulins, particularly IgG, were critical for activation of the complement cascade. We identified Csf2/GM-CSF as a primary complement-dependent inflammatory mediator. Furthermore, using network medicine analysis of a biomarker risk panel from plasma of patients with PAH, we demonstrated that complement signaling can serve as a prognostic factor for clinical outcome in PAH.
Pulmonary hypertension (PH) is a debilitating cardiopulmonary disorder with an average life expectancy ,5 years from the time of diagnosis. Inflammation and immunity have emerged as critical early pathogenic elements of pulmonary arterial hypertension (PAH) (1) (2) (3) . Perivascular and adventitial accumulation of monocytes and macrophages and augmented expression of proinflammatory cytokines and chemokines (GM-CSF, CCL2, CX3CL1, CXCL12, and IL6), have been consistently reported in patients with PAH and experimental preclinical PH models (4) (5) (6) (7) (8) . Moreover, immune dysregulation has been suggested to underlie certain forms of PAH (2, 9) . Nevertheless, the mechanisms triggering initial activation of the immune system and inflammation in noninfectious forms of PAH remain elusive.
The complement system is an essential component of innate immunity; however, it exerts functions beyond those of targeting pathogenic threats. Importantly, this versatile pathway of immune defense can be triggered to become a potent mediator driving various inflammatory diseases (10) . Little is known about the role of complement in PH and PAH pathogenesis, particularly its regulation in hypoxic signaling-"sterile inflammation" (11)-or whether complement is important in PAH clinically. Although several studies of PAH have focused on complement activation in the circulation (12, 13) , emerging evidence suggests an important role for local, tissue-or cell-specific production of complement components and activation of the complement cascade (14) . Complement is activated through three major interconnected pathways: classical, alternative, and lectin (10, 15) . The alternative pathway has received particular attention in diseases characterized by sterile inflammation (11, 16) . A traditional view that activation of the complement cascade by antigen-antibody immune complexes involves only the classical pathway has been recently challenged by studies demonstrating that the lectin and alternative pathways can be triggered by antibodies or immune complexes (17) (18) (19) (20) (21) . An important role of alternative pathway-driven antibodymediated complement activation has been demonstrated in the pathophysiology of aortic aneurysm, rheumatoid arthritis, and ischemia/reperfusion (14, 16, (18) (19) (20) (21) (22) . Importantly, even when complement activation is initiated through classical or lectin pathways, 90% of downstream complement degradation fragments can be generated through the alternative pathway amplification loop (23) .
In this study, we tested the hypothesis that activation of the complement cascade, specifically involving the alternative pathway, is a critical pathobiological mechanism regulating the early proinflammatory and pro-proliferative processes that characterize experimental hypoxic PH. Furthermore, we sought to determine whether there was evidence of complement activation in rodent models of more severe PH (sugen-hypoxia, monocrotaline) and in late-stage human PAH. Finally, we elucidated whether circulating complement components can serve as biomarkers of disease outcome in human PAH.
Some of the results of these studies have been previously reported in the form of abstracts (24, 25) .
Methods Animal Models
Mice (male) were purchased from Jackson Laboratories: C57BL/6J, B10. (26) . Cfb (complement factor B)-deficient (Cfb 2/2 ) mice were bred in-house (27) . WistarKyoto male rats were from Charles Rivers Laboratories. On delivery from the vendor, all animals were acclimatized for at least a week in a sea-level (SL) chamber (barometric pressure [P B ] = 760 mm Hg) because P B is 640 mm Hg at Denver altitude. In-house-bred Cfb 2/2 mice were placed into SL chambers on weaning. Thereafter, control groups remained in SL chambers, whereas experimental groups were placed for 3 days into hypobaric (P B = 380 mm Hg) hypoxic chambers (with oxygen levels approximately 12%; sample size for each SL or hypoxic group was 6-8 rats or 8-12 mice) (4, 28, 29) .
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At a Glance Commentary
Scientific Knowledge on the Subject: The preponderance of data associate complement with pulmonary arterial hypertension (PAH) via analysis of circulating complement components without studying the lung directly. In this study, we attempted to resolve this by analyzing both the local lung-specific processes in experimental animal pulmonary hypertension models and human lung specimens and the correlation of dysregulated complement to clinical outcome in patients with PAH.
What This Study Adds to the Field: We believe our study demonstrates, for the first time, that the immunoglobulin-driven activation of the complement cascade, and specifically its alternative pathway, in the pulmonary vascular adventitia is a critical mechanism initiating proinflammatory responses in pulmonary hypertension and PAH.
ORIGINAL ARTICLE
No specific anti-C3aR1 antibodies are available for mouse Lung cryosections were labeled with species-specific anti-complement C3 antibodies conjugated with green (a, for mouse) or red (b, for rat) fluorochrome. Cell nuclei are labeled with DAPI (blue). Scale bars, 100 mm. (B) Expression of receptors for complement anaphylatoxins C5a and C3a (C5aR1 and C3aR1, respectively) is markedly upregulated in the lungs of animals with experimental pulmonary hypertension. In rodents exposed to hypoxia (HX) for three days (a, mice; b and c, rats), cells expressing C5aR1 and C3aR1 (red fluorochrome) are markedly increased in numbers and localized to perivascular areas, whereas only a few Six IgG-injected hypoxic mMT 2 mice were used. Standard veterinary care was provided in compliance with institutional animal care and use committee-approved protocols at the University Colorado Denver. Specimens of bovine lung tissues were obtained from Holstein neonatal (15-d-old) male calves; the experimental hypoxic group (n = 7) was exposed from Day 1 after birth for 2 weeks to hypobaric hypoxia (P B = 445 mm Hg), whereas agematched controls (n = 6) were kept at ambient altitude (P B = 640 mm Hg), as described previously (4) .
Additional experimental animal information can be found in the online supplement (ANIMAL MODELS).
Human Tissues
Human lung specimens from normal (rejected) donors and patients with idiopathic PAH (IPAH; n = 6, each group, (12) . Nine patients underwent lung or heart and lung transplantation and were censored at this date. Patients were not fasting and were sampled at their routine clinical appointment visits. Peripheral venous blood samples were collected using EDTA. Vacutainer tubes (BD Biosciences) were immediately put on ice, centrifuged (1,300 3 g, 15 min) within 30 minutes of collection, and plasma aliquots were stored at 280 8 C until required.
Complement-PAH network development. Forty prognostic plasma proteins identified in a published proteomic analysis of patients with IPAH or heritable PAH (12) were evaluated, using the (incomplete) consolidated human interactome, which contains information on 170,303 protein-protein interactions (30) (Table E4 ). Nodes in the consolidated human interactome represent proteins, and edges represent functional associations rather than physical protein-protein binding (31) . Expression data from functionally associated proteins in the complement-PAH network were used to determine whether PAH subgroups could be identified from the original PAH study population (12) . We used the "elbow" method to determine the best number of clusters K. The elbow method ran K-means clustering on the data set for a range of values for K (e.g., [1] [2] [3] [4] [5] [6] [7] [8] and, for each value of K, calculated the sum of squared errors (SSE). The optimal number is the elbow position. The underlying assumption with this method is that increasing the number of clusters beyond the elbow position will not further reduce SSE substantially. Using the elbow chart, the greatest decrease in slope for SSE across sequentially clusters was at K 2-3 from K 1-2. Therefore, we selected K = 2 and then used K-means clustering algorithm to cluster the data into two clusters. The network-based patient cluster assignment was tested for association with all-cause mortality from time of sampling by Kaplan-Meier analysis, as described previously (12) . Kaplan-Meier plots illustrating events (deaths) in relation to biomarker levels were assessed by the log-rank test.
Results

Hypoxia Activates the Alternative Pathway of Complement
Little is known about the mechanisms involved in the early initiating stages of PH, especially those shaping pulmonary vascular microenvironments that would further perpetuate vascular remodeling. We sought to examine whether the early responses to sterile environmental stimuli (in the absence of infection or extensive injury) would be associated with complement activation, specifically via the alternative pathway that has been reported in diseases characterized by sterile inflammation (11, 16) . We chose to use a commonly accepted rodent model of hypoxia-induced PH in its early stage (3-d hypoxic challenge), when the cellular processes characteristic of PH pathogenesis Figure 1 . (Continued). pulmonary adventitial cells express these receptors in the lungs of sea-level (SL) animals. Lung cryosections were labeled with species-specific monoclonal antibodies against C5aR1 (mice and rats) and C3aR1 (available for rats only). Autofluorescence of elastic lamellae (green) defines tunica media, and cell nuclei are labeled with DAPI (blue). Scale bars, 100 mm. (Bd) Quantification of red fluorescence was performed as described in the online supplement and is presented in arbitrary units (AU). (Be) qRT-PCR analysis demonstrates that expression levels of C5ar1 and C3ar1 mRNA in the whole lungs of mice and rats are significantly upregulated by 3-day exposure to HX compared with SL controls. Unpaired/two-tailed test was performed for comparing two groups. **P < 0.01, ***P < 0.001, and ****P < 0.0001. AW = airway; PA = pulmonary artery.
(accumulation of monocytes and macrophages, increased cell proliferation) are observed (4, 7, 28, 29) .
Lungs of 3-day hypoxic wild-type (WT) mice and rats demonstrated robust vascularspecific deposition of complement C3, whereas no C3 deposition was detected in SL animals ( Figure 1A ). Furthermore, markedly increased numbers of cells expressing receptors for anaphylatoxins C5a and C3a (C5aR1 and C3aR1, respectively) were observed in perivascular and periairway areas of elastic pulmonary arteries (Figures 1Ba-1Bc , quantified in Figure 1Bd , and confirmed in whole-lung lysates via RT-PCR in Figure 1Be ).
RT-PCR analysis of whole lungs of 3-day hypoxic mice demonstrated robust augmentation of the key activator of the complement alternative pathway, Cfb, and modest increases in complement C3 mRNA but no change in expression of regulators or inhibitors of the alternative pathway, Cfh (complement factor H), and Cd55/Daf ( Figure 2A ). Moreover, no hypoxia-induced changes were detected for complement C4b mRNA (defining the classical and lectin pathways; Figure E1 ). These findings in whole mouse lungs were corroborated by RNA-sequencing analysis of flow-sorted murine lung interstitial macrophages (IMs) in our previously published article (29) , in which hypoxic IMs showed 3.2-fold increases in Cfb and concurrent decreases in Cfh (21.43-fold) and Cd55/Daf (22.47-fold) over SL controls (Table E1) . Because these results suggested hypoxia-induced activation or amplification of the alternative pathway locally within the lung, we sought to identify the cellular source of Cfb. RNAscope in situ hybridization demonstrated minimal Cfb expression in SL mice, whereas robust Cfb upregulation was observed in pulmonary adventitia and airways of hypoxic mice ( Figures 2B and E2) . Thus, the alternative pathway and its activator Cfb emerged as critical hypoxia-induced constituents in the lung vasculature.
Hypoxia-induced Perivascular Inflammation Is Complement Dependent
A distinctive feature of PH is early and persistent perivascular inflammation (3, 4, 32) , as confirmed in 3-day hypoxic WT mice ( Figure E3 ). Using mice genetically deficient in specific complement qRT-PCR analysis of whole lung extracts from wild-type (WT) mice exposed to hypoxia (HX) for 3 days demonstrates robust augmentation of Cfb (complement factor B) and modest upregulation of complement C3 mRNA expression levels compared with sea-level (SL) controls. Unpaired/two-tailed test was performed for comparing two groups. (B) Lungs of 3-day HX WT mice demonstrate robust augmentation of Cfb mRNA expression, as detected via RNAscope in situ hybridization, in cells localized to pulmonary artery (PA) perivascular areas and airways (AWs). Fast Red chromogen (red), used for message detection in in situ hybridization, can be visualized by both light (upper panels) and fluorescent (bottom panels) microscopy. Gill's hematoxylin (blue) was used for nuclear counterstaining in light microscopy imaging (upper panels). (C-E) Attenuated accumulation of CD68 1 macrophages is observed in the lungs of complement (Cfb and C5)-deficient HX mice compared with WT HX counterparts, as validated by CD68 immunostaining (C, red fluorochrome) and its quantification (D) performed as described in the online supplement and presented in arbitrary units (AU), as well as by qRT-PCR of whole lung tissues (E). (Unpaired/two-tailed test was performed for comparing two groups in each cohort). Scale bars, 100 mm. *P , 0.05, **P < 0.01, and ****P < 0.0001; ns = not significant. Cfh = complement factor H; C T = cycle threshold.
components, we tested the hypothesis that hypoxia-induced lung inflammation is complement dependent. Surprisingly, and in contrast to a previous publication (33) (Figures 2C-2E ).
Next we examined expression and localization of Csf2/GM-CSF, a potent cytokine implicated in mobilization and proinflammatory activation of monocytes and macrophages in PAH (34) . In situ hybridization demonstrated that, in SL-WT mice, Csf2 was localized mainly to airways but not to pulmonary vasculature, whereas robust upregulation of Csf2 expression was detected in pulmonary arteries of hypoxic WT mice -deficient HX mice demonstrate significantly decreased mRNA expression levels (E). One-way ANOVA with a Sidak multiple-comparison test with a single pooled variance was performed for multiple-group comparison. Scale bars, 100 mm. *P < 0.05 and ****P < 0.0001; ns = not significant. C T = cycle threshold.
( Figure 3A) . Remarkably, Cfb 2/2 and C5 2/2 mice demonstrated abrogation of hypoxia-induced Csf2 upregulation in lung vasculature. Airways of all mouse strains, SL or hypoxic, maintained Csf2 expression without any significant visual change. This was verified by qRT-PCR demonstrating abrogation of hypoxiainduced Csf2 upregulation in mice deficient in complement (Cfb and C5; Figure 3B ). In addition, we analyzed expression of a potent monocyte chemoattractant, Ccl2/MCP1. In situ hybridization demonstrated significant hypoxia-induced Ccl2/MCP1 upregulation in vasculature and airways ( Figure 3C ), whereas MCP1 protein was detected only in perivascular and adventitial areas ( Figure 3D ). RT-PCR analysis showed potent upregulation of Ccl2 in hypoxic WT lungs but significantly attenuated Ccl2 expression in the lungs of mice deficient in complement (Cfb and C5; Figure 3E ).
Hypoxia-induced Perivascular Cell Proliferation Is Complement Dependent
Augmented lung-cell proliferation is a distinctive characteristic of the early response to hypoxic insult (7), confirmed by increased numbers of replicating Ki67 1 perivascular cells in hypoxic WT lungs ( Figures 4A and 4B ) and markedly augmented mRNA expression of Cdk1 (cyclin-dependent kinase 1) directly involved in cell-cycle progression (35) (Figure 4C Figures 4A-4C) , implicating the complement signaling in partially regulating hypoxia-induced lung-cell proliferation.
Notably, RVSPs of 3-day hypoxic WT and complement-deficient mice were elevated likely because of vasoconstriction at this early time point in the disease process ( Figures E5A-E5C ).
Csf2/GM-CSF Expression and Production by Cultured Pulmonary Fibroblasts Is Complement Dependent
Because we have previously shown that pulmonary perivascular fibroblasts from patients with PAH (termed PH-Fibs; Table  E2 ) exhibit a CSF2/GM-CSF-expressing phenotype (5), we used these cells to evaluate whether the complement signaling directly regulates CSF2/GM-CSF expression and production. Exposure of serum-starved PH-Fibs to complement-sufficient human serum for 2 to 6 hours resulted in profound CSF2 mRNA increases under normoxia (21% O 2 ) and, at 2 hours, under hypoxic conditions, whereas incubation in serum with a selectively inhibited alternative pathway (depleted in CFB) consistently resulted in significant attenuation of CSF2 mRNA (Figures 5Aa and 5Ab ) and protein expression (Figure 5Ac ). Similar findings were obtained with serum depleted of another essential activator of the alternative pathway, CFD (complement factor D; Figure 5B ). On the contrary, CSF2 expression in PH-Fibs was complement C4 (classical pathway) independent ( Figure 5C ). Furthermore, PH-Fibs exposed to serum with inhibited terminal C5 pathway (C5-depleted sera) or with inhibited assembly of membrane-attack complex (MAC; C6-depleted sera) also demonstrated significantly decreased CSF2 expression under hypoxia (3%O 2 , 2 h) but no significant attenuation under normoxia ( Figure 5D ), suggesting a potential role for C5 and sublytical MAC assembly qRT-PCR analysis of whole lung tissues for cell cycle-progression marker Cdk1 (cyclin-dependent kinase 1) expression. One-way ANOVA with a Sidak multiple-comparison test with single pooled variance was performed for multiple-group comparison. *P , 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. AW = airway; PA = pulmonary artery.
specifically in hypoxia-induced increases in CSF2 expression.
Hypoxia-induced IgG Deposition Contributes to Complement Activation and Perivascular Proinflammatory, Pro-proliferative Processes
Having determined an essential role of complement signaling in hypoxia-induced perivascular inflammation and cell proliferation, we next sought to define its upstream triggers. Because previous studies have suggested an important role for (auto)immune mechanisms in the pathophysiology of PH (2, 9), we evaluated the contribution of immunoglobulins to hypoxia-induced complement activation and proinflammatory lung remodeling. Table E2 ), were serum-starved in serum-free medium (SFM) for 72 hours and incubated with complement-sufficient normal human serum (HS) or HS depleted in specific complement components. (A and B) PH-Fibs substantially upregulate CSF2 mRNA (Aa, Ab, and B) and protein (Ac) expression in response to complement-sufficient HS, whereas their responses to serum with inhibited alternative pathway (CFBdpl [complement factor B-depleted], Aa and Ab; CFDdpl [complement factor D-depleted], B) are significantly attenuated. This pattern was observed under both normoxia (NX; 21% O 2 ) and hypoxia (HX; 3% O 2 ) conditions; however, at a 2-hour time point (three different cell populations shown, Aa), the levels of HXinduced CSF2 mRNA expression were higher than those in NX, which was in contrast to a 6-hour time point (n = 5 cell populations shown, Ab). The qRT-PCR findings were confirmed at a protein level via ELISA (Ac) using conditioned medium generated at a 6-hour time point. (C) Expression of CSF2 by PH-Fibs was observed to be independent of complement C4 (main component of the classical and lectin pathways). (D) Two-hour exposure of PH-Fibs to HS depleted in complement C5 (C5dpl) or C6 (C6dpl) resulted in substantial attenuation of CSF2 expression compared with HS under HX (3% O 2 ) but not under NX (21% O 2 ) conditions. *P , 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; ns = not significant. C4dpl = component 4-depleted; C T = cycle threshold.
the pattern of their respective native C4 and C3 components: luminal/medial for C4d and perivascular for C3d ( Figure E6 ). To test whether complement activation is sustained at later time points of hypoxic exposure and in other experimental PH models, as well as in human PAH, we evaluated deposition of C3d (the final activation/degradation fragment of complement C3), which was not detectable at an early, 3-day hypoxic exposure time point but constitutes a commonly accepted marker of complement cascade activation (38) . C3d deposition was consistently (D-F) qRT-PCR analysis of whole lung tissues for mRNA expression of macrophage marker Cd68 (D), Csf2 (E), and Ccl2 (F). One-way ANOVA with a Sidak multiple-comparison test with single pooled variance was performed for multiple-group comparison. (G-I) Hypoxia-induced perivascular cell proliferative responses, defined by immunostaining for nuclear proliferation-associated Ki67 antigen (red, G, quantified in H) and qRT-PCR analysis of whole lung tissues for cell cycleprogression marker Cdk1 (cyclin-dependent kinase 1) expression (I) are significantly attenuated in the lungs of HX mMT mice compared with HX WT counterparts. (G) Autofluorescence of pulmonary artery elastic lamellae (green) defines tunica media; cell nuclei are labeled with DAPI (blue). *P < 0.05 and ****P < 0.0001; ns = not significant. Scale bars, 100 mm. AW = airway; C T = cycle threshold; PA = pulmonary artery. 1 and C5aR1 1 cells (red fluorescence) was performed as described in the online supplement and is presented in arbitrary units (AU). Quantification of IgG and C3 deposition was not performed because the sea-level lung samples were completely observed in a perivascular-specific pattern in the lungs of experimental mice, in rats and calves with chronic (2-3 wk) hypoxic PH, and in rats with sugen-hypoxia PH and monocrotaline PH (Figures 9A and E8A ). In lungs of human patients with IPAH, C3d was detected immunohistochemically in pulmonary perivascular areas, with evidence of less prominent expression within the neointima of arteries with intima thickening (Figures 9Ba and E8B) . The IHC signal of C3d deposition in normal (rejected) lung donors was minimal to absent.
These data decisively demonstrated that complement activation is a longitudinal marker of PH and PAH in different experimental PH models, across species, and at different stages of the disease process. Furthermore, complement activation is initiated and maintained in the pulmonary perivascular areas.
Plasma Complement Is a Critical Determinant of Clinical Outcomes in Patients with PAH
Next we tested whether complement signaling can also serve as a biomarker in the circulation of patients with PAH. Using unbiased analytic methods, we first aimed to determine which complement signaling proteins are clinically relevant to PAH. A biomarker panel of prognostic proteins in PAH (12) (Table E4 ) was mapped to the consolidated human interactome (30) , which includes information on functional associations between proteins that is based on protein-protein interactions. From this approach, we observed that 13 PAH proteins were connected to at least one other PAH protein, corresponding to 18 protein-protein interactions. This network was heavily populated by complement intermediaries, particularly those of the alternative pathway (C3, CFB, CFD, CFH, and CFP) and C7 of the terminal MAC pathway. As such, this was termed the "complement-PAH network" ( Figure 9C ). Next we hypothesized that focusing on functionally related proteins could be informative for determining differences in outcome among patients with PAH. Therefore, a K-means clustering algorithm was performed on the original cohort of patients with PAH (12) using the expression profile of only proteins in the complement-PAH network (39) . The elbow method was used to determine the optimal number of patient clusters (n = 2). The summarized expression profile of proteins in the complement-PAH network alone was sufficient to identify two distinct subgroups of patients with PAH ( Figure 9D ) that corresponded to significant and meaningful differences in the rate of all-cause mortality ( Figure 9E ).
Discussion
This study establishes 1) essential roles for the alternative and C5 complement pathways in initiating lung inflammation through generation of Csf2/GM-CSF and Ccl2/MCP1, perivascular monocyte and macrophage accumulation, and augmentation of cell proliferation; 2) the critical contribution of immunoglobulins, specifically IgG, to complement-driven lung inflammation; 3) perpetuation of perivascular-specific activation of the complement cascade in the lungs of various experimental animal PH models and humans with PAH; and 4) complement signaling (the alternative pathway, in particular) as an important correlative determinant of clinical outcomes in patients with PAH.
The complement system plays an essential role in defensive immune processes. However, dysregulated complement activation may turn this beneficial protective system into a destructive tissue-damaging villain, as shown in various inflammatory, autoimmune, and ischemic disorders (10) . Mounting experimental data unveil the relative involvement of each of the three activation pathways (classical, lectin, and alternative) in complement-mediated tissue injury and remodeling. In the present study, we identified the activated alternative pathway as an essential regulator of hypoxia-induced proinflammatory and pro-proliferative changes in the lung. Similar findings of alternative pathway activation were recently reported by high-throughput analysis of the plasma proteome in patients with PAH, in which increases in the activator of the alternative pathway, CFD, and decreases in the inhibitor CFH identified patients with PAH with high risk of mortality (12) .
An important and novel finding of this study demonstrates, both in vivo and in vitro, complement (alternative and C5 pathways)-dependent vascular-specific regulation of Csf2/GM-CSF expression and production. GM-CSF has emerged as a potent key mediator of tissue inflammation (40) . Locally produced at sites of inflammation, GM-CSF promotes recruitment, prosurvival reprograming, and proinflammatory activation of monocytes and macrophages and participates in induction of inflammasome (34, 41 1 monocyte expansion is dependent on GM-CSF signaling. An elegant recent study by the Rabinovitch group demonstrated that GM-CSF is a critical mediator of monocyte and macrophage recruitment and PH and PAH development (34) . Our findings corroborate this exciting report by showing that attenuated Csf2 expression corresponds with reduced monocyte and macrophage recruitment; however, the novelty of our findings is in delineating the molecular mechanisms underlying Csf2/GM-CSF regulation (i.e., complement dependence) and demonstrating that GM-CSF is an essential downstream mediator of complement-induced injury in PH. Our in vivo data also demonstrate complement (alternative and C5 pathways)-dependent regulation of hypoxia-induced Ccl2/MCP1 expression and cell proliferation. Several reports have suggested Csf2/GM-CSF-dependent Figure 8 . (Continued). negative for the staining. (F-I) qRT-PCR analysis demonstrates augmented expression of Cd68 (macrophage marker), Csf2 and Ccl2 (cytokine and chemokine, respectively), and Cdk1 (cyclin-dependent kinase 1; cell cycle-progression marker) in the whole lungs of HX immunoglobulin-deficient mMT mice that were reconstituted with circulating IgG (HX 1 IgG) compared with PBS-injected HX mMT mice.*P , 0.05, ***P < 0.001, and ****P < 0.0001. AW = airway; C5aR1 = receptor for anaphylatoxin C5a; C T = cycle threshold. ) is most prominently observed in a perivascular-specific manner in the lungs of experimental animal models of hypoxic PH (mouse, rat, and calf), sugen-hypoxia (SU-HX) PH and monocrotaline-PH (MCT-PH) rat models, and humans with IPAH. OCT-embedded lung cryosections of experimental animal specimens (A) and formalin-fixed paraffin-embedded sections of human lung specimens (B) were labeled with a biotinylated C3d-specific monoclonal antibody (mAb; red in A, brown in B), developed by Thurman and colleagues (38) . This mAb distinguishes tissuebound C3d from the intact C3 or C3b, allowing assessment of tissue-specific activation of the complement cascade. (A) Exposure of experimental animals to sustained hypoxia was performed for 3 weeks for mice and rats (n = 5, each group) and 2 weeks for calves (n = 5, each group); control (CO) animals were maintained at sea-level (SL) or ambient (Denver, Colorado) altitude. An image of the SU-HX rat model is shown at 2 weeks of hypoxic exposure (the most proinflammatory time point), and an image of the MCT-PH rat lung sample is shown at a 2-week time point. Autofluorescence of pulmonary artery (PA) elastic lamellae (green) defines tunica media in hypoxic experimental animal models and in human specimens, whereas a-smooth muscle actin defines tunica media in MCT-PH and SU-HX lung specimens. Images of C3d immunofluorescent staining for all analyzed human specimens are shown in Figure E8A . IPAH and normal (rejected for lung transplant) donor cohorts are described in Table E3A . Cell nuclei are labeled with DAPI (blue). Scale bars, 100 mm. (Ba) Immunohistochemistry (IHC) staining demonstrates C3d deposition in a medium-sized PA of a patient with IPAH. The C3d IHC signal is largely restricted to perivascular areas. Cohorts of patients with IPAH and CO (rejected for lung transplant) donors (n = 6, each) are described in Table E3 . Images of C3d IHC staining of all analyzed human specimens (n = 6, each cohort) are shown in Figure E8B . (Bb) Quantification of IHC staining was performed via MetaMorph software, in which the dynamic range for gray intensity levels ranges between 0 (white) and 256 (black). Background levels of (Table E4) with prognostic importance to patients with PAH (n = 218) were analyzed using a network medicine approach. Differentially expressed proteins were mapped to the consolidated human interactome resulting in a network that was enriched with complement pathway intermediaries, referred to in this article as the complement-PAH network (13 proteins and 18 protein-protein interactions). (D) Two distinct PAH patient clusters were identified based on biological information derived solely from the complement-PAH network. Oval represents the estimated cluster boundaries determined by the patient data in each cluster. (E) Previously published data (12) identifying circulating proteins (Table E4) with prognostic importance to patients with PAH (n = 218) were analyzed using a network medicine approach. A total of 37 differentially expressed proteins were mapped to the consolidated human interactome resulting in the complement-PAH network. Kaplan-Meier survival estimates in patients with PAH divided into two clusters (as shown in D) based on the plasma levels of proteins in the complement-PAH network are presented; thin vertical marks indicate where patients were censored during the time course. ***P < 0.001. AW = airway; OCT = optimal cutting temperature compound; PC = principal component.
important results. This provides further context toward clarifying the molecular mechanisms underpinning the role of complement in PH and PAH. The relevance of experimental animal data to the human condition was validated by our findings of similar perivascular-specific patterns of complement activation (C3d deposition) in the lungs of PH animals and patients with IPAH. Importantly, a perivascular-specific pattern of complement activation, localization of C3ar1/C5ar1-expressing cells, and IgG deposition provides further support for the essential role of the adventitia in PH-associated inflammatory processes (7, 8) .
In conclusion, the data of this study establish a causal role for complement activation and immunoglobulins in the early, initiating, proinflammatory stage of experimental hypoxic PH and propose the alternative pathway of complement signaling as a prognostic factor in clinical PAH. Dysregulated complement signaling thus emerges as a persistent longitudinal determinant of PH and PAH pathobiology. Because the etiology of PH and PAH remains elusive, further delineation of diagnostic and predictor targets in the initial asymptomatic preclinical period would facilitate development of more effective prevention and treatment strategies. n Author disclosures are available with the text of this article at www.atsjournals.org.
